These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1372948)

  • 21. [Epidemiological and clinical significance of HCV antibody--future problems].
    Nishioka K
    Nihon Rinsho; 1991 Feb; 49(2):267-72. PubMed ID: 1849181
    [No Abstract]   [Full Text] [Related]  

  • 22. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening blood donations for HCV.
    Maclennan S; Barbara JA; Hewitt P; Moore C; Contreras M
    Lancet; 1992 Jan; 339(8785):131-2. PubMed ID: 1345863
    [No Abstract]   [Full Text] [Related]  

  • 24. [Possibilities and limits of anti-HCV antibody screening in the blood donation service].
    Fölsch B; Gabriel C; Wilders-Truschnig MM; Lanzer G
    Infusionsther Transfusionsmed; 1994 Dec; 21(6):388-92. PubMed ID: 7533014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second generation anti-HCV test: seroprevalence in hemodialysis patients and blood donors.
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Transplant Proc; 1992 Dec; 24(6):2648-9. PubMed ID: 1334595
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis C--screening of blood donations.
    Walsh TJ
    Ir Med J; 1991 Jun; 84(2):41-2. PubMed ID: 1716620
    [No Abstract]   [Full Text] [Related]  

  • 27. [Serological study on hepatitis C (HCV) in 4371 blood donors].
    Arnone M; Pinducciu G; Usai M; Pitzus F; Pintus L
    Ann Ig; 1990; 2(5):353-8. PubMed ID: 1715726
    [No Abstract]   [Full Text] [Related]  

  • 28. Heterosexual transmission of hepatitis C virus in family groups without risk factors.
    Peano GM; Fenoglio LM; Menardi G; Balbo R; Marenchino D; Fenoglio S
    BMJ; 1992 Dec; 305(6867):1473-4. PubMed ID: 1283543
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
    Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
    Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Liatek HCV: the six-antigen test for confirmation of the presence of anti-HCV antibodies].
    Juszczyk J; Flieger J; Migdalski P; Skalisz H
    Przegl Epidemiol; 1992; 46(1-2):11-7. PubMed ID: 1282266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abbott HCV EIA 2nd generation: a new screening assay.
    Weise W; Bäcker U; Seidl S; Flacke H; Sondag D; Pirenne H; Schroeter E; Troonen H; Broeksma C; Heyermann H
    Beitr Infusionsther; 1992; 30():34-7. PubMed ID: 1284729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiological study of hepatitis C virus (HCV) infection in plasmapheresis and blood donors].
    Jin ZL; Chen SQ; Shi ZY
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Aug; 16(4):234-6. PubMed ID: 7585906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Seroepidemiological study on hepatitis C virus infection among blood donors from various regions in China].
    Tang S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Oct; 14(5):271-4. PubMed ID: 7511060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-transfusion hepatitis C virus infection.
    Kleinman S; Busch M; Holland P
    N Engl J Med; 1992 Nov; 327(22):1601-2. PubMed ID: 1279422
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anti-HCV antibodies against the structural and nonstructural antigens of hepatitis C in people seropositive in the second generation test].
    Juszczyk J; Flieger J; Migdalski P; Skalisz H
    Przegl Epidemiol; 1992; 46(3):159-65. PubMed ID: 1284256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infectivity of blood that is immunoblot intermediate reactive on hepatitis C virus antibody testing.
    Bellobuono A; Mozzi F; Petrini G; Zanella A; Sirchia G
    Lancet; 1990 Aug; 336(8710):309. PubMed ID: 1973990
    [No Abstract]   [Full Text] [Related]  

  • 38. HCV confirmatory testing of blood donors.
    Follett EA; Dow BC; McOmish F; Yap PL; Crawford RJ; Mitchell R; Simmonds P
    Lancet; 1992 Apr; 339(8798):928. PubMed ID: 1348314
    [No Abstract]   [Full Text] [Related]  

  • 39. Natural horizontal transmission of HCV in microepidemic town in Japan.
    Tajima K; Shimotohno K; Oki S
    Lancet; 1991 Jun; 337(8754):1410-1. PubMed ID: 1674778
    [No Abstract]   [Full Text] [Related]  

  • 40. HCV confirmatory testing of blood donors.
    Gesinde MO; Love EM; Lee D
    Lancet; 1992 Apr; 339(8798):928-9. PubMed ID: 1348315
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.